trending Market Intelligence /marketintelligence/en/news-insights/trending/TWWbvO2tWR8PAtflDcAPng2 content esgSubNav
In This List

AFT, Angelini partner to license cold, flu product in 16 additional countries

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


AFT, Angelini partner to license cold, flu product in 16 additional countries

AFT Pharmaceuticals Ltd. entered an alliance agreement with Angelini Acraf SpA to license AFT's Maxiclear patented combination cold-and-flu product line in an additional 16 countries.

The added countries include Italy, San Marino, Vatican City, Spain, Portugal, Greece, Bulgaria, Croatia, Czech Republic, Slovakia, Austria, Romania, Poland, Hungary, Turkey and Russia.